UK markets closed

Autolus Therapeutics plc (AUTL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.32-0.01 (-0.19%)
At close: 4:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
30/09/2018
30/09/2017
Total revenue
1,646
1,715
2,908
1,407
1,693
Operating expenses
Research development
134,332
134,888
105,418
36,150
16,012
Selling general and administrative
36,096
34,972
39,452
22,790
9,099
Total operating expenses
170,428
169,860
144,870
58,940
25,111
Operating income or loss
-168,782
-168,145
-141,962
-57,533
-23,418
Interest expense
-
-
-
12.667
-
Total other income/expenses net
-2,966
1,352
412
3,970
-46
Income before tax
-171,678
-166,257
-139,008
-52,031
-23,380
Income tax expense
-26,191
-24,163
-15,159
-7,280
-3,653
Income from continuing operations
-145,487
-142,094
-123,849
-44,751
-19,727
Net income
-145,487
-142,094
-123,849
-44,751
-19,727
Net income available to common shareholders
-145,487
-142,094
-123,849
-44,751
-19,727
Basic EPS
-
-2.76
-2.88
-0.99
-0.45
Diluted EPS
-
-2.76
-2.88
-0.99
-0.45
Basic average shares
-
51,558
43,066
31,557
43,900
Diluted average shares
-
51,558
43,066
31,557
43,900
EBITDA
-
-162,487
-137,351
-55,824
-22,409